ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1599542
Novel perceptions of the involvement of CPZ in gastric cancer prognosis and immunomodulation
Provisionally accepted
- 1Guangxi Medical University, Nanning, China
- 2Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong Province, China
- 3First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Gastric cancer (GC) is a highly malignant tumor with a complex etiology. Most patients are diagnosed at an advanced stage with poor prognosis. The carboxypeptidase family is associated with progression in many cancers. Carboxypeptidase Z (CPZ) is a cellular matrix regulator. Corresponding studies on CPZ expression and the molecular mechanisms of GC prognosis and immunomodulation are lacking. We examined the influence of CPZ expression on the prognosis and immunomodulation of GC and the corresponding clinical significance. Methods: CPZ gene expression in pan-cancer analysis was conducted using the Tumor Immune Estimation Resource (TIMER2.0) database. Differences in CPZ expression levels were investigated using 412 GC samples and 36 normal tissue samples from The Cancer Genome Atlas (TCGA) database. These results were validated using the Gene Expression Profiling Interactive Analysis (GEPIA2) and Gene Expression Omnibus (GEO) datasets GSE65801 and GSE103236. The prognostic and diagnostic value of CPZ expression in patients with GC was assessed using Kaplan-Meier plotter, the chi-square test, and the receiver operating characteristic (ROC). Genes with joint CPZ differential expression were identified for functional enrichment analysis according to TCGA-STAD database. The link between CPZ and immune cell infiltration, immune checkpoints, and fibroblasts was determined using CIBERSORT, single-sample gene set enrichment analysis, and the TIMER2.0 immuno-gene module. The tumor mutational burden and immunotherapy were analyzed using maftools and The Cancer Imaging Archive data. CPZ expression-related drug susceptibility was analyzed using R oncoPredict package and Wilcoxon tests. Differential CPZ expression in cancer and paracancerous tissues was verified using immunohistochemistry (IHC) and quantitative PCR (qPCR). Results: The analysis demonstrated significantly increased CPZ expression in GC tissues. The CPZ expression level was an independent GC prognostic factor of risk. CPZ expression influenced immune cell and fibroblast infiltration in the GC tumor microenvironment. Elevated CPZ expression led to patient resistance to common chemotherapeutic agents such as oxaliplatin, docetaxel, and cisplatin. IHC and qPCR demonstrated significantly increased CPZ expression in GC tissues. Conclusion: Elevated CPZ expression in GC tissues affects patient survival prognosis and can increase immune cell infiltration, affecting the tumor microenvironment. CPZ may be a novel predictive biomarker associated with immune-modulated prognosis in GC.
Keywords: gastric cancer1, CPZ2, bioinformatics analysis3, Immune regulation4, Prognosis5
Received: 25 Mar 2025; Accepted: 14 Aug 2025.
Copyright: © 2025 Yuan, Yang, Huang, Wei and Tian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lei Tian, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Region, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.